CIK 0001472012
- Non-accelerated filer
Immunome Inc.
Sign in to watch- Ticker
- IMNM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770694340
- Phone
- +1 610-321-3700
- Business address
- 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 5,000 shares at $9.38 ($46,900)
- 4 Option exercise Chief Scientific Officer acquired 5,200 shares (option exercise)
- 4 Open-market buy Director bought 7,800 shares at $7.78 ($60,684)
- 4 Open-market buy President and CEO bought 137,100 shares at $7.29 ($999,459)
- 4 Open-market buy Director bought 7,000 shares at $8.21 ($57,470)
- 4 Open-market buy Chief Technology Officer bought 12,300 shares at $8.42 ($103,566)
- 4 Open-market buy President and CEO bought 150,000 shares at $7.75 ($1,162,500)
- 4 Open-market buy President and CEO bought 100,000 shares at an average $9.62 ($962,181)
- 4 Open-market buy Chief Medical Officer bought 15,805 shares at $9.48 ($149,800)
Page 3 of 10 · 187 filings